Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28140466 | 0.98 | ALDH1A1 (0.46) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL20599687 | 0.93 | — | — | |
| SCHEMBL8447826 | 0.87 | — | — | |
| SCHEMBL13224367 | 0.87 | MAPT (0.38) | ALDH1A1ADRB2ADRB1ADRB3KMT2A | |
| SCHEMBL10099631 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL205737 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL8845363 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL3404743 | 0.82 | ALDH1A1 (0.46) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL26136682 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KMT2AMEN1SMN1; SMN2MAPT | |
| SCHEMBL4959177 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CES2CES1ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11236210-B2 | Heat shrinkable film composition comprising polyethyleneterephtalate resin and polyester based copolymer, and heat shrinkable film | SK CHEMICALS CO., LTD. | 2022-02-01 | — | — | US | claimed |
| US-10723852-B2 | Heat shrinkable film composition comprising polyethyleneterephtalate resin and polyester based copolymer, and heat shrinkable film | SK CHEMICALS CO., LTD. (KR) | 2020-07-28 | — | — | US | claimed |
| EP-0832077-B1 | IMPROVED ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS | DU PONT PHARM CO (US) | 2001-11-14 | — | — | EP | claimed |
| US-5961483-A | Iontophoretic delivery of cell adhesion inhibitors | COLLATERAL AGENTS, LLC | 1999-10-05 | — | — | US | claimed |
| US-5811441-A | INHIBITION OF PLATELET AGGREGATION; TREATMENT OF AUTOIMMUNE DISEASES | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-09-22 | — | — | US | claimed |
| WO-1997048444-A1 | IONTOPHORETIC DELIVERY OF CELL ADHESION INHIBITORS | BECTON DICKINSON AND COMPANY (US) | 1997-12-24 | — | — | WO | claimed |
| WO-1997023456-A1 | INDOLOQUINONE DERIVATIVES AS BIOREDUCTIVE AGENTS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1997-07-03 | — | — | WO | claimed |
| US-4464373-A | 4,5-Dihydroimidazo-[1,2-a]quinoxaline-2-carboxylic acids and their derivatives with antiallergic activity | ROUSSEL UCLAF (FR) | 1984-08-07 | — | — | US | claimed |
| EP-4719605-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | GlaxoSmithKline Intellectual Property (No.4) Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024246863-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024246862-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) LIMITED (GB) | 2024-12-05 | — | — | WO | disclosed |
| EP-4452965-A1 | CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2024-10-30 | — | — | EP | disclosed |
| EP-4423094-A1 | RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE | Bristol-Myers Squibb Company (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-4284863-A2 | METHOD FOR DECOLORIZING A COLORED SYNTHETIC OR NON-SYNTHETIC POLAR-POLYMER MATERIAL | Smart Coloring GmbH (DE) | 2023-12-06 | — | — | EP | disclosed |
| WO-1997048443-A1 | IONTOPHORETIC DELIVERY OF CELL ADHESION INHIBITORS | BECTON DICKINSON AND COMPANY (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1997048444-A1 | IONTOPHORETIC DELIVERY OF CELL ADHESION INHIBITORS | BECTON DICKINSON AND COMPANY (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1997023456-A1 | INDOLOQUINONE DERIVATIVES AS BIOREDUCTIVE AGENTS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1997-07-03 | — | — | WO | disclosed |
| WO-1996037482-A1 | IMPROVED ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-11-28 | — | — | WO | disclosed |
| US-4464373-A | 4,5-Dihydroimidazo-[1,2-a]quinoxaline-2-carboxylic acids and their derivatives with antiallergic activity | ROUSSEL UCLAF (FR) | 1984-08-07 | — | — | US | disclosed |
| US-4464373-A | 4,5-Dihydroimidazo-[1,2-a]quinoxaline-2-carboxylic acids and their derivatives with antiallergic activity | ROUSSEL UCLAF (FR) | 1984-08-07 | — | — | US | disclosed |